Neurogene
$38.13
20
-$0.47-1.22% Tuesday 20:00
+$0.00+0%Tuesday 21:36After hours
Statistics
Day High
38.34
Day Low
37.61
52W High
43.66
52W Low
15.93
Volume
11,471
Avg. Volume
-
Mkt Cap
763.03M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
23NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.53
-1.35
-1.17
-0.99
Expected EPS
-1.332222
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-90.35MNet Income
Analyst Ratings
104.00Average Price Target
The highest estimate is 166.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NGNE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
Show more...
CEO
Rachel L. McMinn
Employees
131
Country
United States
ISIN
US64135M1053
WKN
000A3EX79
Listings
0 Comments
Share your thoughts
FAQ
What is Neurogene stock price today?▼
The current price of NGNE is $38.13 USD — it has decreased by -1.22% in the past 24 hours. Watch Neurogene stock price performance more closely on the chart.
What is Neurogene stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Neurogene stocks are traded under the ticker NGNE.
Is Neurogene stock price growing?▼
NGNE stock has fallen by -0.6% compared to the previous week, the month change is a +6.84% rise, over the last year Neurogene has showed a +98.08% increase.
What is Neurogene market cap?▼
Today Neurogene has the market capitalization of 763.03M
When is the next Neurogene earnings date?▼
Neurogene is going to release the next earnings report on November 23, 2026.
What were Neurogene earnings last quarter?▼
NGNE earnings for the last quarter are -1.53 USD per share, whereas the estimation was -1.42 USD resulting in a -7.49% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Neurogene revenue for the last year?▼
Neurogene revenue for the last year amounts to 0 USD.
What is Neurogene net income for the last year?▼
NGNE net income for the last year is -90.35M USD.
How many employees does Neurogene have?▼
As of September 09, 2026, the company has 131 employees.
In which sector is Neurogene located?▼
Neurogene operates in the Health & Wellness sector.
When did Neurogene complete a stock split?▼
The last stock split for Neurogene was on December 19, 2023 with a ratio of 1:4.
Where is Neurogene headquartered?▼
Neurogene is headquartered in NEW YORK, United States.